Log In
BCIQ
Print this Print this
 

Interleukin-1 (IL-1) beta

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Interleukin-1 (IL-1) beta

BCIQ
Print ChartPrint this
1 - Inflammation 1 - Endocrine / Metabolic 1 - Autoimmune 1 - Ophthalmic 1 - Inflammation 1 - Dermatology 1 - Cardiovascular 1 - Autoimmune 1 - Renal 1 - Inflammation 2 - Endocrine / Metabolic 1 - Dermatology 2 - Cardiovascular 4 - Autoimmune 1 - Ophthalmic 1 - Inflammation 2 - Neurology 1 - Inflammation 3 - Endocrine / Metabolic 3 - Dermatology 1 - Cardiovascular 1 - Cancer 4 - Autoimmune
Phase of DevelopmentPreclinicalPhase IPhase I/IIPhase IIPhase IIIMarketed
Autoimmune

4

-

-

4

1

1

Cancer

1

-

-

-

-

-

Cardiovascular

1

-

-

2

1

-

Dermatology

3

-

-

1

1

-

Endocrine / Metabolic

3

-

-

2

-

1

Inflammation

1

1

-

1

1

1

Neurology

2

-

-

-

-

-

Ophthalmic

-

-

1

-

1

-

Renal

-

-

-

1

-

-




 Products Targeting Interleukin-1 (IL-1) beta
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

6

$885.0M

$15.4M

$800.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today